Generic tirzepatide applications filed in the US
Awaiting primary-source check
Two manufacturers have filed abbreviated new drug applications for generic tirzepatide. Acceptance of a filing is not approval, and the originator holds patents running to 2036, so this does not mean cheaper tirzepatide is imminent in the UK or anywhere else.
Sources
Told first, next time
This story reached you late. A short email when a licence changes, a safety alert lands, or a trial reports. No selling, no advertising, no sharing your address.
What this is. A dated, sourced note on something that changed. Peptide Register is an independent reference: it sells nothing, carries no advertising, and takes no money from any company selling any compound it covers. This is not medical advice. If a change affects a medicine you are prescribed, speak to your doctor or pharmacist rather than acting on something you read here.